Recombinant Factor C Assay Market: Report Analysis, Share, Revenue, Growth Rate With Forecast Overview 2022-2031

Japan, Japan, Mon, 21 Mar 2022 05:40:28 / Comserve Inc. / -- Recombinant Factor C Assay Market :Global Size, Share, Trends, Forecast, Growth, Key Players, Market Segments & Regional Analysis (Latin America, North America, Asia Pacific, Europe, Middle East)

"The report on Recombinant Factor C Assay Market was recently published by SDKI, which includes the latest market trends, current and future opportunities along with the factors that are driving the growth of the market. This report further encompasses the records for the expansion of the market along with information on the investment opportunities that help the clients to take positive decisions on the parameters for gaining profitable revenues. Moreover, the report also contains identification and investigation of the market structure, in-depth qualitative analysis, restraints & challenges, growth drivers, emerging product trends & market opportunities and Porter's five forces.

Download Sample of This Strategic Report: https://www.sdki.jp/sample-request-110390

Recombinant Factor C Assay Market: Overview

• The global recombinant factor C assay market was valued at ~US$ 13 Mn in 2018 and is projected to expand at a considerable CAGR from 2022-2031. Endotoxin detection is a crucial step before the launch of pharmaceutical drugs, medical devices, and biotechnology products for human use. Recombinant factor C assay has been accepted as an alternative to LAL tests, which are widely employed for endotoxin testing. This growing acceptance as an alternative to LAL tests and its inclusion in the regulatory pharmacopoeias would contribute to the growth of the recombinant factor C assay market.   
• Significant advantages offered by recombinant factor C assays, including cost advantages by aiding in reducing the operator risks by lowering the rate of invalid results and reduction of over 50% of the processing time as compared to the conventional microplate-based LAL tests, contribute to the growth of the recombinant factor C assays market
• Productivity of the pharmaceutical industry has been significantly high, with an increase in the number of drugs approved annually. According to the U.S. FDA, in 2018, over 59 new drugs were approved in the U.S. Additionally, increase in demand for personalized medicine aids in the rise in the product approvals. This contributes to the growth of the recombinant factor C assays market.

Recombinant Factor C Assay Market: Segmentation

• The global recombinant factor C assay market has been segmented based on brand, end user, and region
• In terms of brand, the global recombinant factor C assay market has been categorized into PyroGene and EndoNext. The PyroGene brand is sub-segmented into PyroGene Bulk rFC (2,880 tests) and PyroGene rFC (192 tests). The EndoNext brand is sub-segmented into EndoZyme II, EndoZyme II GO, and EndoLisa. 
• Based on end user, the global recombinant factor C assay market has been segregated into pharmaceutical companies, biotechnology companies, medical device companies, and contract research organizations (CROs). The pharmaceutical companies segment dominated the market in 2018, and is likely to remain dominant during the forecast period. Growth of the segment can be attributed to increase in approvals of pharmaceutical drugs globally. In addition, rise in demand for personalized medicines contributes to increase in manufacturing of pharmaceuticals, thereby leading to rise in the number of endotoxin detection tests conducted. This would contribute to the growth of the pharmaceutical companies segment in the recombinant factor C assay market.

Recombinant Factor C Assay Market: Regional Segmentation

• In terms of region, the global recombinant factor C assay market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• North America dominated the global recombinant factor C assay market in 2018 and the trend is expected to continue throughout the forecast period
• The recombinant factor C assay market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Incorporation of recombinant factor C as a recognized endotoxin detection test by pharmacopoeias, and focus on conservation of the Limulus species in Asia Pacific contributes to the growth of the recombinant factor C assay market in the region.

Recombinant Factor C Assay Market: Major Players

• Key players operating in the global recombinant factor C assay market are Lonza Group and Hyglos GmbH – a bioMérieux Company 
• These players are focused on adopting inorganic growth strategies and product launches to strengthen their product portfolio. In June 2018, bioMérieux launched rapid ENDOZYME II GO, a new endotoxin test in the bioMérieux ENDONEXT range of recombinant horseshoe crab factor C assays. bioMérieux entered the market in 2016, through the acquisition of Hyglos, a company engaged in the development of recombinant factor C assays for endotoxin testing.

Recombinant Factor C Assay Market - Scope of the Report

The report on the global recombinant factor C assay market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global recombinant factor C assay market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global recombinant factor C assay market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global recombinant factor C assay market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global recombinant factor C assay market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global recombinant factor C assay market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global recombinant factor C assay market. The next section of the report highlights the USPs, which include value chain analysis, key industry developments, patent analysis, regulatory scenario, and institutes involved in research studies using horseshoe crabs in the global recombinant factor C assay market.

The report delves into the competition landscape of the global recombinant factor C assay market. Key players operating in the global recombinant factor C assay market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global recombinant factor C assay market report.

Key Questions Answered in Global Recombinant Factor C Assay Market Report

• How much sales revenue would be generated by recombinant factor C assay across all regions during the forecast period?
• What are key trends in the global recombinant factor C assay market?
• What are major drivers, restraints, and opportunities in the global recombinant factor C assay market?
• Which regional market is set to expand at the most rapid CAGR during the forecast period?
• Which end user segment would generate the maximum revenue by 2027 and which brand segment would expand at the most rapid CAGR during the forecast period?

Recombinant Factor C Assay Market - Research Objectives and Research Approach

The comprehensive report on the global recombinant factor C assay market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global recombinant factor C assay market. It is followed by market introduction, market dynamics, and an overview of the global recombinant factor C assay market, which includes Tanalysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global recombinant factor C assay market report highlights the USPs, which include regulatory scenarios for recombinant factor C assay globally, market value chain analysis, and developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

For more information about this report visit: Recombinant Factor C Assay Market"

Revenue generated by key players in the global recombinant factor C assay market has been mapped to ascertain the size of the global recombinant factor C assay market, in terms of value. The forecast presented here assesses the total revenue generated in the global recombinant factor C assay market. In order to provide an accurate forecast, we initiated by sizing up the current recombinant factor C assay market with the help of the parent market.

The report analyzes the global recombinant factor C assay market in terms of brand, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global recombinant factor C assay market.

Get a Sample Copy of the Report@ https://www.sdki.jp/sample-request-110390

Table of Content
1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Recombinant Factor C Assay Market

5. Market Overview

5.1. Definition

5.2. Market Indicators

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

5.4. Global Recombinant Factor C Assay Market Revenue (US$ Mn) Forecast 2017–2027

5.5. Global Recombinant Factor C Assay Market Outlook

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

The post Recombinant Factor C Assay Market: Report Analysis, Share, Revenue, Growth Rate With Forecast Overview 2022-2031 appeared first on Comserveonline.